News and Events

Subscribe to our press distribution list to receive the latest news about AMW.

Upcoming

Events

CPHI Barcelona

24-26 October 2023 – Fira Barcelona Gran Via, Spain CPHI Barcelona is the largest pharma event of the year, making it the ideal opportunity for pharma professionals to learn, network and collaborate with the best in the industry. AMW is on site for the first time and is very much looking forward to meeting you […]

read more
Latest

News

AMW Expands Leadership Team for Strategic Expansion

Warngau, Germany, November 28, 2023 AMW GmbH, a specialty pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the expansion of its leadership team to implement its strategic growth strategy. Following Philipp Karbach taking over the role of Chief Executive Officer (CEO) in June this year, Sebastian Herzog now strengthens the management team […]

read more

AMW reports financial results for fiscal 2022 and updates on corporate performance

AMW GmbH, a pharmaceutical company specializing in innovative drug delivery systems, today released its financial results for the year ended December 31, 2022. AMW reported record consolidated sales for 2022 of €22.8 million and achieved operating profitability for the first time in the company’s history. The company also reported that Philipp Karbach will assume the position of chief executive officer (CEO) effective June 1, 2023, as Dr. Konstantin Petropoulos has decided to step down as CEO of AMW GmbH effective May 31, 2023, to pursue new opportunities. Philipp Karbach joined AMW in 2016, most recently in his role as Chief Operating Officer (COO) and Chief Financial Officer (CFO).

read more

AMW Appoints Professor Olivia Merkel to the Scientific Advisory Board

AMW GmbH, a pharmaceutical company specializing in innovative drug delivery systems, today announced the appointment of Prof. Dr. Olivia Merkel, Professor of Drug Delivery at the Faculty of Chemistry and Pharmacy of Ludwig-Maximilians-Universität (LMU) Munich, as a member of its Scientific Advisory Board (SAB). Prof. Merkel is an internationally recognized expert in novel and targeted drug delivery systems, including RNA delivery systems. Her appointment will strengthen AMW’s scientific expertise in sustained-release delivery systems, such as biodegradable implants, and contribute to the company’s strategic development plans. With her appointment, Prof. Merkel succeeds Prof. Dr. Gerhard Winter, who will step down from his position on the Scientific Advisory Board.

read more

AMW and SAJA Pharmaceuticals sign license and supply agreement for commercialization of AMW’s goserelin implant

AMW GmbH, a pharmaceutical company specializing in innovative drug delivery systems, and SAJA Pharmaceuticals, a leading regional drug manufacturer based in Jeddah, Saudi Arabia, with a presence in the MENA (North Africa and Middle East) states, announced today that they have entered into an exclusive licensing and supply agreement. The agreement covers the commercialization of AMW’s goserelin implant in the Kingdom of Saudi Arabia.

read more

For press and news inquiries please send an e-mail to news@a-m-w.eu